Recruiting now
-
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Phase 2 · 20 people · 2 sites in United States · Recruiting now
-
Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI
Phase 3 · randomised · 254 people · 1 site in France · Recruiting now
-
ROMANCE: “Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer”
Phase 2 · randomised · 150 people · 26 sites in Italy · Recruiting now
-
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Not phased · randomised · 84 people · 1 site in Greece · Recruiting now
-
Neoadjuvant Radiotherapy vs Upfront Surgery in Locally Advanced Proximal Rectal Cancer
Not phased · randomised · 100 people · 1 site in Turkey (Türkiye) · Recruiting now